This important volume describes the latest advances in all areas of
interleukin-5 (IL5) research, pooling the insights of over 65 biological researchers, pharmaceutical scientists, and clinicians, representing institutions as diverse as the Mayo Clinic, the National Lung and Heart Institute, the John Curtin School of Medical Research, the Geneva Biomedical Research Institute, the Flanders'
Interuniversity Institute for Biotechnology, and the University of Tokyo. Details IL5-related antiallergy drugs currently
in development at Glaxo Wellcome and Schering-Plough Research Institute! Reviewing approaches toward small molecule antagonists and inhibitors, Interleukin-5 · highlights the structure…
